"Murta de Oliveira, Cláudia" - Selaus tekijän mukaan TUNICRIS-julkaisut

Viitteet 1-1 / 1

    • The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster : Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70 

      Zoster-049 Study Group; Boutry, Céline; Hastie, Andrew; Diez-Domingo, Javier; Tinoco, Juan Carlos; Yu, Chong Jen; Andrews, Charles; Beytout, Jean; Caso, Covadonga; Cheng, Huey Shinn; Cheong, Hee Jin; Choo, Eun Ju; Curiac, Dan; Di Paolo, Emmanuel; Dionne, Marc; Eckermann, Tamara; Esen, Meral; Ferguson, Murdo; Ghesquiere, Wayne; Hwang, Shinn Jang; Avelino-Silva, Thiago Junqueira; Kosina, Pavel; Liu, Chiu Shong; Markkula, Jukka; Moeckesch, Beate; Murta de Oliveira, Cláudia; Park, Dae Won; Pauksens, Karlis; Pirrotta, Paola; Plassmann, Georg; Pretswell, Carol; Rombo, Lars; Salaun, Bruno; Sanmartin Berglund, Johan; Schenkenberger, Isabelle; Schwarz, Tino; Shi, Meng; Ukkonen, Benita; Zahaf, Toufik; Zerbini, Cristiano; Schuind, Anne; Cunningham, Anthony L. (04 / 2022)
      article
      BACKGROUND: This ongoing follow-up study evaluated the persistence of efficacy and immune responses for 6 additional years in adults vaccinated with the glycoprotein E (gE)-based adjuvanted recombinant zoster vaccine (RZV) ...